IA
EW icon

Inspire Advisors’s Edwards Lifesciences EW Stock Holding History

Inspire Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$987K Buy
+12,329
New +$1.02M 0.08% 195
2024
Q1 		– Sell
-6,763
Closed -$516K – 391
2023
Q4 		$516K Sell
6,763
-1,100
-14% -$76.5K 0.08% 170
2023
Q3 		$545K Buy
+7,863
New +$632K 0.1% 124
2022
Q2 		– Sell
-4,513
Closed -$531K – 134
2022
Q1 		$531K Buy
4,513
+1,823
+68% +$205K 0.15% 24
2021
Q4 		$349K Buy
+2,690
New +$314K 0.1% 48

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Inspire Advisors's EW Position: Q1 2026 in Review

Inspire Advisors opened a new position in Edwards Lifesciences (EW) in Q1 2026: 12,329 shares worth $987K. The stake represents 0.08% of the portfolio and ranks #195 among its holdings. This is a return to the name: Inspire Advisors previously reported a position in EW as recently as Q4 2023.

Inspire Advisors first reported a position in EW in Q4 2021 and has held it in 5 quarters since. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Inspire Advisors held 12,329 shares of Edwards Lifesciences worth $987K as of Q1 2026.
  • Edwards Lifesciences was a new Inspire Advisors position in Q1 2026.
  • Edwards Lifesciences made up 0.08% of Inspire Advisors's portfolio in Q1 2026, its #195 holding.
  • Inspire Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 5 quarters since.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.